BioLineRx annual revenue
2021
2022
2023
2024
2025
BioLineRx Revenue Growth & History (BLRX)
BioLineRx reported $1.2M in revenue for fiscal 2025, a decrease of 95.92% from the previous fiscal year.
View full BioLineRx company overviewBioLineRx annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.2M | −$27.8M | −95.92% |
| 2024 | 2024-12-31 | $28.9M | $24.1M | +502.92% |
| 2023 | 2023-12-31 | $4.8M | $4.8M | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | — | — |
BioLineRx quarterly revenue
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $294,000 | −$10,000 | −3.29% |
| Q1 2026 | 2026-03-31 | $477,000 | $222,000 | +87.06% |
| Q4 2025 | 2025-12-31 | $194,000 | — | — |
| Q3 2025 | 2025-09-30 | $427,000 | — | — |
| Q2 2025 | 2025-06-30 | $304,000 | −$5.1M | −94.36% |
| Q1 2025 | 2025-03-31 | $255,000 | — | — |
| Q2 2024 | 2024-06-30 | $5.4M | $5.4M | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
BioLineRx revenue growth trends
BioLineRx's latest reported quarter, Q2 2026, generated $294,000 in revenue, a decrease of 3.29% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review BioLineRx source filings ↗